These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 32425074)

  • 1. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
    Basisty N; Kale A; Patel S; Campisi J; Schilling B
    Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomic atlas of senescence-associated secretomes for aging biomarker development.
    Basisty N; Kale A; Jeon OH; Kuehnemann C; Payne T; Rao C; Holtz A; Shah S; Sharma V; Ferrucci L; Campisi J; Schilling B
    PLoS Biol; 2020 Jan; 18(1):e3000599. PubMed ID: 31945054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation methodology is essential to the evaluation of the extracellular vesicle component of the senescence-associated secretory phenotype.
    Wallis R; Josipovic N; Mizen H; Robles-Tenorio A; Tyler EJ; Papantonis A; Bishop CL
    J Extracell Vesicles; 2021 Feb; 10(4):e12041. PubMed ID: 33659050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies.
    Dey AK; Banarjee R; Boroumand M; Rutherford DV; Strassheim Q; Nyunt T; Olinger B; Basisty N
    Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senopathies-Diseases Associated with Cellular Senescence.
    Lushchak O; Schosserer M; Grillari J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype.
    Jakhar R; Crasta K
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of extracellular vesicles as a senescence-associated secretory phenotype: Insights into the pathophysiology of lung diseases.
    Kadota T; Fujita Y; Yoshioka Y; Araya J; Kuwano K; Ochiya T
    Mol Aspects Med; 2018 Apr; 60():92-103. PubMed ID: 29146100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell GG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; Lebrasseur NK; Farr JN; Robbins PD; Khosla S
    Aging (Albany NY); 2023 May; 15(9):3331-3355. PubMed ID: 37154858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Senescence: A Translational Perspective.
    Kirkland JL; Tchkonia T
    EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases.
    Cuollo L; Antonangeli F; Santoni A; Soriani A
    Biology (Basel); 2020 Dec; 9(12):. PubMed ID: 33371508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
    Niklander SE; Lambert DW; Hunter KD
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Proteomic Analysis of the Senescence-Associated Secretory Phenotype by Data-Independent Acquisition.
    Neri F; Basisty N; Desprez PY; Campisi J; Schilling B
    Curr Protoc; 2021 Feb; 1(2):e32. PubMed ID: 33524224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
    Rossi M; Abdelmohsen K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.